NDX Taps Insider Paul Kahn as Interim CEO to Steer Digital Future
- $2.3 billion: The North American dental prosthetics market in 2025, projected to more than double to over $5 billion by 2035.
- 30+ laboratories: NDX operates a network of over 30 labs and employs nearly 1,500 professionals.
- 16 months: Kevin Mosher's tenure as CEO before Paul Kahn's interim appointment.
Experts would likely conclude that NDX's appointment of Paul Kahn as interim CEO underscores a strategic focus on accelerating digital transformation, leveraging his operational and financial expertise to position the company as a leader in modern dental prosthetics technology.
NDX Taps Insider Paul Kahn as Interim CEO to Steer Digital Future
PALM BEACH GARDENS, Fla. – March 16, 2026 – National Dentex Labs (“NDX”), North America's largest network of fully-owned dental laboratories, has appointed insider Paul Kahn as its Interim Chief Executive Officer, effective immediately. The move signals a strategic doubling-down on digital innovation as the company navigates a rapidly evolving market. Kahn, who has served as the company's Chief Operating, Transformation & Financial Officer since May 2025, succeeds Kevin Mosher, whose tenure as CEO began in November 2024.
The appointment places a leader with a deep background in organizational transformation and finance at the helm of the dental prosthetics giant. Kahn's promotion from a role that explicitly combined operations with transformation underscores the company's commitment to accelerating its technological capabilities and streamlining its vast network of over 30 laboratories and nearly 1,500 professionals.
A Mandate for Digital Transformation
Since joining NDX less than a year ago, Kahn has been a central figure in the company's push to modernize. His efforts have focused on aligning financial strategy with operational execution, specifically by spearheading initiatives to advance the company's digital workflows. This transition is critical in an industry where precision, speed, and efficiency are paramount.
NDX is at the forefront of integrating cutting-edge technology like CAD/CAM (Computer-Aided Design/Computer-Aided Manufacturing) systems, 3D printing, and intraoral scanners into the traditional craft of creating dental prosthetics. These technologies are revolutionizing the production of everything from crowns and bridges to complex implant restorations and digital dentures. The goal is to create a seamless connection between the dentist's office and the laboratory, reducing turnaround times and enhancing clinical accuracy.
In a statement, Kahn emphasized that this technological push is fundamentally about service. "As we accelerate our digital capabilities, we remain first and foremost a service-driven company, ensuring that our innovation is always led by a customer-centric approach that supports the unique needs of every clinician we serve," he said. "My focus will be on maintaining this momentum, ensuring we deploy the best in modern dentistry to support our partners and their patients. This is an exciting chapter, and I am committed to driving the progress and excellence that NDX is known for."
Kahn's professional history suggests he is well-equipped for this mandate. His career includes senior leadership roles at major corporations like Viacom and Warner Chappell Music, where he was Executive Vice President and CFO. He also served as CFO for the TikTok competitor Triller ahead of a planned public offering, giving him experience in high-growth, tech-centric environments. This blend of experience in large-scale operations and nimble, tech-driven companies appears tailor-made for NDX's current strategic pivot.
Navigating a Shifting Market Landscape
Kahn's appointment comes at a pivotal moment for the North American dental prosthetics market. Valued at over $2.3 billion in 2025, the sector is projected to more than double to over $5 billion by 2035, driven by a confluence of powerful trends. An aging population is increasing the demand for restorative dental work, while a growing consumer focus on aesthetics is fueling interest in high-quality, natural-looking solutions.
Simultaneously, the industry is undergoing significant consolidation. The high capital investment required for state-of-the-art digital equipment is making it difficult for smaller, independent labs to compete. This has led to a wave of mergers and acquisitions, with larger entities like NDX expanding their footprint to achieve economies of scale and offer a more comprehensive suite of services. As the largest network of fully-owned labs, NDX is a major force in this consolidation trend, and its digital strategy is a key competitive advantage.
By investing heavily in technology and providing extensive training and support for its partner dentists, NDX is positioning itself not just as a producer of dental products, but as a crucial technology partner for modern dental practices. This includes offering intraoral scanner rebate programs and hands-on training to help clinicians make the leap to fully digital workflows.
Leadership in Transition
The leadership transition itself is noteworthy. Kevin Mosher, a seasoned executive with experience at ClearChoice Dental Implant Centers and Nobel Biocare, held the CEO position for approximately 16 months. While leadership changes are a constant in corporate life, the appointment of an interim CEO often signals a specific strategic phase. In this case, Kahn's 'interim' status suggests the board is prioritizing the execution of its digital transformation agenda while it considers its long-term leadership plan.
Appointing an internal executive like Kahn, who is already deeply embedded in the company's transformation strategy, ensures continuity and momentum on key projects. It allows the company to make bold moves without the ramp-up period a new, external CEO would require. This structure gives Kahn the mandate to drive necessary changes and accelerate the integration of technology across the NDX network, while providing the board with time to conduct a thorough search for a permanent successor who will guide the company's next chapter of growth.
From the Lab to the Patient
Ultimately, the impact of NDX's strategy extends beyond corporate boardrooms and laboratory floors to the dental chair itself. The shift to digital dentistry holds the promise of significant benefits for both clinicians and their patients. For dentists, digital workflows mean greater predictability and accuracy, with digital impressions from intraoral scanners eliminating the inaccuracies and patient discomfort associated with traditional physical molds.
For patients, this technological leap can translate into a better experience and superior outcomes. Digitally designed and milled restorations often provide a more precise fit, enhanced aesthetics, and greater durability. Furthermore, the efficiency gains from digital processes can lead to faster treatment times, meaning fewer appointments and quicker access to necessary dental prosthetics. As NDX continues to push the boundaries of digital innovation under Kahn's leadership, it is not just reshaping a company, but also influencing the future standard of restorative dental care across North America.
